Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

CCI-779 in Treating Patients With Malignant Glioma

NCT00022724

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

NCT00006358

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

NCT00025675

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Neuro-Oncology Branch Bethesda, Maryland, United States
View Trial Details
Completed

An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)

NCT01990248

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • LKH Feldkirch; Onkologie Feldkirch, Austria
  • Ordensklinikum Linz Elisabethinen ; Dermatologie Linz, Austria
  • Krankenhaus Hietzing Wien Vienna, Austria
  • ZNA Middelheim Antwerp, Belgium
View all 80 locations
View Trial Details
Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

NCT00002569

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Glioma, +11 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 95 locations
View Trial Details
Completed

Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma

NCT02696356

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Christ Hospital Cancer Research Cincinnati, Ohio, United States
  • Providence Health and Services, Providence Portland Medical Center Portland, Oregon, United States
  • University of Pittsburg Pittsburgh, Pennsylvania, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details

Related conditions